Article
Galectin-3 drives neuroinflammatory amyloid remodeling by stabilizing intermediate Aβ species and altering lysosomal processing
2025-03-17
Abstract excerpt
Neuroinflammation is a hallmark of Alzheimer’s disease (AD), yet the molecular mediators driving microglial dysfunction and neurotoxicity remain poorly understood. Here, we identify Galectin-3 (Gal3) as a central regulator of plaque-associated microglial responses, linking amyloid-beta (Aβ) aggregation, lysosomal function and plaque-associated neuritic damage. Using postmortem brain tissue from AD patients, we dem...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fc208275-a544-5ea6-b002-879ab17dd1e4
- DOI
- 10.1101/2025.03.17.643790
